Harbin Gloria Pharmaceuticals (002437) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.084x

Based on the latest financial reports, Harbin Gloria Pharmaceuticals (002437) has a cash flow conversion efficiency ratio of 0.084x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.89 Million ≈ $26.76 Million USD) by net assets (CN¥2.18 Billion ≈ $318.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Harbin Gloria Pharmaceuticals to measure how many days the company can operate on defensive assets alone.

Harbin Gloria Pharmaceuticals - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Harbin Gloria Pharmaceuticals's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Harbin Gloria Pharmaceuticals Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Gloria Pharmaceuticals ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Suning Universal Co Ltd SHE:000718	0.008x
EQ Resources Ltd AU:EQR	-0.169x
BeiJing Certificate Authority Co Ltd SHE:300579	-0.075x
Myers Industries Inc NYSE:MYE	0.091x
Center Laboratories TWO:4123	0.002x
Shenzhen Sosen Electronics Co.Ltd. SHE:301002	-0.007x
Seneca Foods Corp A NASDAQ:SENEA	0.044x
Tongyang Life KO:082640	1.300x

Annual Cash Flow Conversion Efficiency for Harbin Gloria Pharmaceuticals (2007–2025)

The table below shows the annual cash flow conversion efficiency of Harbin Gloria Pharmaceuticals from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Harbin Gloria Pharmaceuticals.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.31 Billion ≈ $337.96 Million	CN¥273.36 Million ≈ $40.00 Million	0.118x	-43.18%
2024-12-31	CN¥1.97 Billion ≈ $288.69 Million	CN¥410.94 Million ≈ $60.13 Million	0.208x	+29.93%
2023-12-31	CN¥1.71 Billion ≈ $250.26 Million	CN¥274.18 Million ≈ $40.12 Million	0.160x	+4.39%
2022-12-31	CN¥1.70 Billion ≈ $249.28 Million	CN¥261.62 Million ≈ $38.28 Million	0.154x	+10.84%
2021-12-31	CN¥1.98 Billion ≈ $289.58 Million	CN¥274.18 Million ≈ $40.12 Million	0.139x	+1998.19%
2020-12-31	CN¥1.93 Billion ≈ $282.85 Million	CN¥12.76 Million ≈ $1.87 Million	0.007x	-98.28%
2019-12-31	CN¥1.59 Billion ≈ $232.45 Million	CN¥610.37 Million ≈ $89.32 Million	0.384x	+45.20%
2018-12-31	CN¥4.39 Billion ≈ $642.95 Million	CN¥1.16 Billion ≈ $170.15 Million	0.265x	+72.66%
2017-12-31	CN¥4.25 Billion ≈ $622.28 Million	CN¥651.80 Million ≈ $95.38 Million	0.153x	-40.39%
2016-12-31	CN¥4.05 Billion ≈ $592.15 Million	CN¥1.04 Billion ≈ $152.26 Million	0.257x	+27.19%
2015-12-31	CN¥3.47 Billion ≈ $508.18 Million	CN¥702.05 Million ≈ $102.73 Million	0.202x	-6.96%
2014-12-31	CN¥3.10 Billion ≈ $453.95 Million	CN¥674.04 Million ≈ $98.63 Million	0.217x	+18.87%
2013-12-31	CN¥2.48 Billion ≈ $362.66 Million	CN¥453.02 Million ≈ $66.29 Million	0.183x	+109.59%
2012-12-31	CN¥2.36 Billion ≈ $345.46 Million	CN¥205.89 Million ≈ $30.13 Million	0.087x	+49.01%
2011-12-31	CN¥2.20 Billion ≈ $321.54 Million	CN¥128.61 Million ≈ $18.82 Million	0.059x	+10.24%
2010-12-31	CN¥2.12 Billion ≈ $310.33 Million	CN¥112.59 Million ≈ $16.48 Million	0.053x	-91.06%
2009-12-31	CN¥287.53 Million ≈ $42.07 Million	CN¥170.82 Million ≈ $25.00 Million	0.594x	+99.41%
2008-12-31	CN¥194.04 Million ≈ $28.39 Million	CN¥57.81 Million ≈ $8.46 Million	0.298x	-21.12%
2007-12-31	CN¥138.36 Million ≈ $20.25 Million	CN¥52.26 Million ≈ $7.65 Million	0.378x	--

About Harbin Gloria Pharmaceuticals

SHE:002437 China Drug Manufacturers - Specialty & Generic

Market Cap

$861.43 Million

CN¥5.89 Billion CNY

Market Cap Rank

#9737 Global

#2596 in China

Share Price

CN¥2.64

Change (1 day)

-1.49%

52-Week Range

CN¥2.64 - CN¥4.04

All Time High

CN¥11.06